Review of Radiation Technologies for the Treatment of Covid-19 Coronavirus Infection
Abstract and keywords
Abstract (English):
Due to the long-term lack of effective pharmacological concepts, the situation with the spread of a new coronavirus infection in 2019 (COVID-19) has aroused interest in considering the possible use of radiation technologies, including historical reports on the treatment of patients with pneumonia using low-dose radiation therapy. A brief review of articles on clinical trials of radiation technologies in the fight against COVID-19 is conducted. The authors of most of the analyzed articles, as well as the authors of this review, conclude that the available scientific data do not justify clinical trials of low-dose radiation therapy for the treatment of COVID-19 pneumonia due to the unclear benefits and risks of mortality from radiation-induced diseases, including radiogenic cancer and diseases of the circulatory system.

Keywords:
coronavirus 2019-nCoV (SARS-CoV-2), radiation technologies, low-dose radiation therapy, radiation risk
References

1. WHO Coronavirus Disease (COVID-19) Dashboard: URL: https://covid19.who.int/ date of request: 20.12.2020

2. Coronavirus Update (Live). https://www.worldometers.info/coronavirus/ date of request 20.12.2020

3. Pandemic Preparedness - GARDP. https://gardp.org/what-we-do/pandemic-preparedness/ date of request 206.12.2020

4. The atomic structure of the shell of the new coronavirus explained its exceptional contagiousness. https://nauka.tass.ru/nauka/ 7777131. date of request 16.12.20

5. Deng X, Gu W, Federman S, du Plessis L, et al. Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California. Science. 2020. 31;369(6503):582-7

6. Salomaa S, Bouffler SD, Atkinson MJ, et al. Is there any supportive evidence for low dose radiotherapy for COVID-19 pneumonia? Int J Rad Biol. 2020. 96(10):1228-35.

7. Hertzog RG, Bicheru SN Radiotherapy in the fight against pneumonia associated with SARS-CoV-2, Int J Rad Biol, 2020: 96(11), 1319-22

8. Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. 2020. 10(2):102-8.

9. ICRP. Publication 103. 2009, 258 p.

10. Lara PC, Burgos J, Macias D. Low dose lung radiotherapy for COVID-19 pneumonia. The rationale for a cost-effective anti-inflammatory treatment. Clin.Transl Radiat Oncol. 2020. 23:27-9;

11. Hamming I, Timens W, Bulthuis ML, Lely AT et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004. 203(2):631-7

12. Varga Z, Flammer AJ, Steiger P. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395(10234):1417-8.

13. Azimzadeh O, Subramanian V, Stander S et al. Proteome analysis of irradiated endothelial cells reveals persistent alteration in protein degradation and the RhoGDI and NO signaling pathways. Int J Radiat Biol. 2017; 93(9):920-8.

14. Onoda JM, Kantak SS, Diglio CA. Radiation induced endothelial cell retraction in vitro: Correlation with acute pulmonary edema. Pathol Oncol Res. 1999. 5(1):49-55.

15. Powell EV Radiation therapy of lobar pneumonia. JAMA. 1938. 110(1): 19-22.

16. Duxbury M H. Atypical pneumonia with x-ray findings simulating tuberculosis. Am Pract Dig Treat. 1947; 1(5):273-5;

17. Little MP, Zhang W, van Dusen R, Hamada N Pneumonia After Bacterial or Viral Infection Preceded or Followed by Radiation Exposure: A Reanalysis of Older Radiobiologic Data and Implications for Low Dose Radiation Therapy for Coronavirus Disease 2019 Pneumonia. Int J Radiat Oncol Biol Phys. 2020; 1e10. https://doi.org/10.1016/j.ijrobp.2020.09.052

18. Calabrese E, Dhawan G. How radiotherapy was historically used to treat pneumonia: could it be useful today? Yale J Biol Med. 2013; 86(4):555-70;

19. Das IJ, Kalapurakal JA, Mittal BB. Caution warranted for low-dose radiation therapy for Covid-19. Br J Radiol. 2020;93: 20200466;

20. Sun SH, Chen Q, Gu HJ, et al. A mouse model of SARS-CoV-2 infection and pathogenesis. Cell Host Microbe. 2020; 28(1): 124-33.

21. Rödel F., Frey B., Manda K., et al. Immunomodulatory properties and molecular effects in inflammatory diseases of low-dose x-irradiation. Front Oncol. 2012; 25;2:120.

22. Rödel F, Arenas M, Ott OJ, et al. Low-dose radiation therapy for COVID-19 pneumopathy: what is the evidence? Strahlenther Onkol. 2020; 196(8): 679-82.

23. Kirkby Ch., Mackenzie M. Is low dose radiation therapy a potential treatment for COVID-19 pneumonia? Radiother Onc. 2020: 147 221

24. Metcalfe PE Low dose radiation therapy for COVID-19 pneumonia: brief review of the evidence. Physical and Engineering Sciences in Medicine. 2020. https://doi.org/10.1007/ s13246-020- 00915-x;

25. Hess DC, Eldahshan W, Rutkowski E. COVID-19-related stroke. Transl Stroke Res. 2020. 11(3):322-5.

26. Kefayat A, Ghahremani F. Low dose radiation therapy for COVID-19 pneumonia: a double-edged sword. Radiother Oncol. 2020; 147:226.

27. Dubrova Y.E., Sarapultseva E.I. Radiation-induced transgenerational effects in animals, Int J Rad Biol. 2020. DOI:https://doi.org/10.1080/09553002.2020.1793027

28. Dhawan G, Kapoor R, Dhawan R, et al. Low dose radiation therapy as a potential lifesaving treatment for COVID-19-induced acute respiratory distress syndrome (ARDS). Radiother Oncol. 2020. 147:212-6

29. Hess CB, Buchwald ZS, Stokes W et al. Low-Dose Whole-Lung Radiation for COVID-19 Pneumonia: Planned Day-7 Interim Analysis of an Ongoing Clinical Trial. Cancer. 2020: 126(23):5109-13

30. Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J Emerg Med. 2020. DOIhttps://doi.org/10.1016/j.ajem.2020.04.048;

31. Kirsch DG, Diehn M, Cucinotta FA, Weichselbaum R. Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable. Radiother Oncol. 2020; 147:217-20.

32. Trott KR, Zschaeck S, Beck M. Radiation therapy for COVID-19 pneumopathy. Radiother Oncol. 2020; 147:210-11

Login or Create
* Forgot password?